Literature DB >> 17495051

Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions.

Amy H Tang1, Gregory J Brunn, Marilia Cascalho, Jeffrey L Platt.   

Abstract

TLRs are usually thought to recognize substances produced by microorganisms and thus, to initiate host defenses. This concept, however, fails to explain some functions of this family of receptors. Recognition of endogenous substances may explain the broader functions of TLRs in physiology and disease. Activation of TLRs by endogenous substances necessitates vigorous control of the function of the receptors. This communication will summarize a line of research, which points to an endogenous agonist for TLR4 and a putative mechanism for controlling the function of that receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495051     DOI: 10.1189/jlb.1206752

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

1.  Nucleic acid-binding polymers as anti-inflammatory agents.

Authors:  Jaewoo Lee; Jang Wook Sohn; Ying Zhang; Kam W Leong; David Pisetsky; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

2.  Contribution of Toll-like receptor activation to lung damage after donor brain death.

Authors:  Anthony J Rostron; David M W Cork; Vassilios S Avlonitis; Andrew J Fisher; John H Dark; John A Kirby
Journal:  Transplantation       Date:  2010-10-15       Impact factor: 4.939

Review 3.  TLR4 Polymorphisms and Expression in Solid Cancers.

Authors:  Nilesh Pandey; Alex Chauhan; Neeraj Jain
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

4.  Microarray analysis of differentially expressed background genes in rats following hemorrhagic shock.

Authors:  Yu Xiaojun; Qian Cheng; Zhang Yuxing; Hu Zhiqian
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

5.  Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice.

Authors:  Kondapalli Mrudula Spurthi; Mohsen Sarikhani; Sneha Mishra; Perumal Arumugam Desingu; Shikha Yadav; Swathi Rao; Sangeeta Maity; Ankit Kumar Tamta; Shweta Kumar; Shamik Majumdar; Aditi Jain; Aishwarya Raghuraman; Danish Khan; Ishwar Singh; Rosa J Samuel; Subbaraya G Ramachandra; Dipankar Nandi; Nagalingam R Sundaresan
Journal:  J Biol Chem       Date:  2018-06-21       Impact factor: 5.157

6.  Adenosine reduces cell surface expression of toll-like receptor 4 and inflammation in response to lipopolysaccharide and matrix products.

Authors:  Benjamin Haas; Frederique Leonard; Isabelle Ernens; Sophie Rodius; Melanie Vausort; Magali Rolland-Turner; Yvan Devaux; Daniel R Wagner
Journal:  J Cardiovasc Transl Res       Date:  2011-05-03       Impact factor: 4.132

7.  Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury.

Authors:  David J Kaczorowski; Atsunori Nakao; Kenneth R McCurry; Timothy R Billiar
Journal:  Curr Cardiol Rev       Date:  2009-08

8.  Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.

Authors:  Ebbe Billmann Thorgersen; Anne Pharo; Karin Haverson; Anne K Axelsen; Peter Gaustad; Girish J Kotwal; Georgia Sfyroera; Tom Eirik Mollnes
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

9.  CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs.

Authors:  Ebbe Billmann Thorgersen; Bernt Christian Hellerud; Erik Waage Nielsen; Andreas Barratt-Due; Hilde Fure; Julie Katrine Lindstad; Anne Pharo; Erik Fosse; Tor Inge Tønnessen; Harald Thidemann Johansen; Albert Castellheim; Tom Eirik Mollnes
Journal:  FASEB J       Date:  2009-10-19       Impact factor: 5.191

10.  Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart.

Authors:  David J Kaczorowski; Atsunori Nakao; Raghuveer Vallabhaneni; Kevin P Mollen; Ryujiro Sugimoto; Junichi Kohmoto; Brian S Zuckerbraun; Kenneth R McCurry; Timothy R Billiar
Journal:  Transplantation       Date:  2009-05-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.